A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year Extension
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 122 (2) , 183-194
- https://doi.org/10.1016/s0002-9394(14)72009-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Double-Masked, Randomized 1-Year Study Comparing Dorzolamide (Trusopt), Timolol, and BetaxololArchives of Ophthalmology (1950), 1995
- Four-Week Safety and Efficacy Study of Dorzolamide, a Novel, Active Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1993
- Dose Response and Duration of Action of Dorzolamide, a Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1992
- MK-507 (L-671,152), a Topically Active Carbonic Anhydrase Inhibitor, Reduces Aqueous Humor Production in MonkeysArchives of Ophthalmology (1950), 1991
- MK-507 versus SezolamideOphthalmology, 1991
- Topical Timolol Administration Reduces the Incidence of Glaucomatous Damage in Ocular Hypertensive IndividualsArchives of Ophthalmology (1950), 1989
- Long-term Evaluation of 0.25% Levobunolol and Timolol for Therapy for Elevated Intraocular PressureArchives of Ophthalmology (1950), 1988
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVESBiometrika, 1954